Molecular-Targeted Therapy For Malignant Mesothelioma
PLEURA · 2015
DOI: 10.1177/2373997515600403 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLEURA, 2015. Verfasst von Yuji Tada und 5 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 83 Literaturangaben.
Abstract (Originalsprache)
Malignant pleural mesothelioma (MPM) is an intractable disease associated with asbestos exposure, and the number of affected patients will increase in the coming decades. The clinical outcome associated with current treatments is unsatisfactory, and the chemotherapy regimen for mesothelioma has remained unchanged for the past 10 years. Emerging molecular-targeted therapies are a novel way to treat other types of tumors and have been shown to drastically improve clinical response and patient prognosis. Some of these targeted agents had promising effects on MPM at the preclinical level and in various clinical trials that have been conducted over the last decade. Contrary to our expectations, results from the majority of these studies were disappointing and many were terminated at an early stage. No useful predictive or prognostic biomarkers were identified for mesothelioma treatment. Nevertheless, some novel strategies involving focal adhesion kinase inhibitors and immune checkpoint targeting agents showed some antitumor effects. In this article, we review the outcomes of previous clinical trials using molecular-targeted agents and discuss several hurdles that need to be overcome, which hopefully will contribute to a better understanding of this rare malignancy.
Zitieren
APA
Tada, Y., Suzuki, T., Shimada, H., Hiroshima, K., Tatsumi, K., & Tagawa, M. (2015). Molecular-Targeted Therapy For Malignant Mesothelioma. PLEURA. https://doi.org/10.1177/2373997515600403
Vancouver
Tada Y, Suzuki T, Shimada H, Hiroshima K, Tatsumi K, Tagawa M. Molecular-Targeted Therapy For Malignant Mesothelioma. PLEURA. 2015. doi:10.1177/2373997515600403
BibTeX
@article{Tada2015,
author = {Tada, Yuji and Suzuki, Toshio and Shimada, Hideaki and Hiroshima, Kenzo and Tatsumi, Koichiro and Tagawa, Masatoshi},
title = {Molecular-Targeted Therapy For Malignant Mesothelioma},
journal = {PLEURA},
year = {2015},
doi = {10.1177/2373997515600403}
}
EUVIMED